Hi-Tech Pharmacal (HITK)
Create an Alert
33.89
-0.02 -0.06%
NASDAQ
Jun 19, 5:00PM
BATS Real time
Currency in USD
Pro Data Export
Hi-Tech Pharmacal Key Statistics
Currency in USD
Current Valuation
Dividends and Shares
| Shares Outstanding | 13.57M |
| Dividend | 1.50 |
| Dividend Yield | 0% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Latest Dividend Date | Dec. 28, 2012 |
| Latest Ex-Dividend Date | Dec. 11, 2012 |
| Last Split Factor | 1.50 |
| Last Split Date | Jan. 12, 2006 |
Profitability
| Gross Profit Margin Quarterly | 51.11% |
| Profit Margin Quarterly | 9.23% |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 6.669 |
| Debt to Equity Ratio | 0.0054 |
| Free Cash Flow | 2.416M |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | 5.02% |
| Year to Date Stock Returns | -3.12% |
| 1 Year Stock Returns | 15.94% |
| 3 Year Stock Returns | 39.06% |
| 52 Week High | 38.17 |
| 52 Week Low | 27.35 |
Income Statement
Cash Flow Statement
| Cash from Financing TTM | -11.64M |
| Cash from Investing TTM | -12.17M |
| Cash from Operations TTM | 37.06M |
| Capital Expenditures Quarterly Pro | Go Pro |
Balance Sheet
| Cash and ST Investments | 87.60M |
| Long Term Debt | 1.332M |
| Total Assets | 288.66M |
| Liabilities | 40.15M |
| Shareholders Equity | 248.51M |
| Book Value | 248.51M |
| Book Value Per Share | 18.31 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
HITK News
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| HITK | 33.89 | -0.02 | -0.06% | 459.92M |
